Juno Therapeutics soared 47 percent after the Wall Street Journal reported that biotech drugmaker Celgene might buy it. The Standard & Poor's 500 index rose 13 points, or 0.5 percent, to 2,790. The Dow Jones industrial average rose 173 points, or 0.7 percent, to 25,966. The Nasdaq composite…
News
- Markets Right Now: Tech, health care lead stock gains
- Tech, health care companies help lift US stocks higher
DEAL TALK: Juno Therapeutics soared 50.9 percent after the Wall Street Journal reported that biotech drugmaker Celgene might buy it. Juno is one of several companies developing therapies that involve genetically engineering patients' blood cells to fight cancer. Juno rose $23.23 to $68.83.…
- How SA's venture capital pipeline flowed to finish 2017
Dominion Aesthetic Technologies is a San Antonio-based biotechnology startup founded in 2015 and focused on commercializing new plastic and reconstructive surgery techniques. The company raised $1.6 million from MagnaSci Ventures, a Houston-based venture capital group. Dominion Aesthetic…
- GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to ...
In 2016, BioBridge Global and GenCure led a team including the U.S. Army Institute of Surgical Research and biotech firms Rooster Bio (based in Maryland) and StemBioSys (based in San Antonio), which was awarded a $7.8-million contract from the Medical Technology Enterprise Consortium (MTEC)…
- San Antonio's Bioscience-Medicine Industry Could Help Solve City's Top Health Problems
Working to leverage the city's biomedical assets, like locally-based research and hospitals, the plan aims to fuel economic growth and harness San Antonio's strengths to become a global healthcare resource. What is the impact of healthcare and bioscience on San Antonio's economy? How can the…